Pacific Biosciences of California Inc. buy Cantor Fitzgerald
Start price
31.10.23
/
50%
€6.27
Target price
31.10.24
€10.36
Performance (%)
-68.90%
End price
01.11.24
€1.95
Summary
This prediction ended on 01.11.24 with a price of €1.95. Massive losses of -68.90% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacific Biosciences of California Inc. | -0.613% | -0.613% | -14.318% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $11.00 price target on the stock.
Ratings data for PACB provided by MarketBeat
In the thread Trading Pacific Biosciences of California Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.41
08.08.24
08.08.24
€3.21
08.08.25
08.08.25
-19.66%
09.08.25
09.08.25
